The spectrum and pathogenesis of antibody-mediated neuropathies

Neuroscientist

Volumn 3, Issue 3, 1997, Pages 195-204

  Quarles, Richard H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Antibody; Ganglioside; Myelin associated glycoprotein; Neuropathy; Sulfoglucuronyl paragloboside

Indexed keywords

EID: 0001483612     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849700300313     Document Type: Article

References (58)

1. Posner JB. Anti-Hu autoantibody associated sensory neuropathy/ encephalomyelitis: a model of paraneoplastic syndrome. Perspect Biol Med 1995;38:167-181.
2. Dalakas MC, Quarks RH. Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens? Ann Neurol 1996;39:419-422.
3. Svennerholm L, Asbury A, Reisfeld R, et al. Biological function of gangliosides. Prog Brain Res 1994;101.
4. Jungalwala FB. Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system - a review. Neurochem Res 1994;19:945-957.
5. Quarles R, Colman D, Salzer J, Trapp B. Myelin-associated glycoprotein. In: Martenson R, editor. Myelin: biology and chemistry. Boca Raton, FL: CRC Press 1992;4413-4448.
6. Fruttiger M, Montag D, Schachner M, Martini R. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 1995;7:511-515.
7. Quarles RH. Human monoclonal antibodies associated with neuropathy. Methods Enzymol 1989;179:291-299.
8. Marcus DM, Latov N, Hsi BP, Gillard BK. Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A. J Neuroimmunol 1989;25:255-259.
9. Daune GC, Farrer RG, Dalakas MC, Quarles RH. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside. Ann Neurol 1992;31:683-685.
10. Thomas P, Willison H. Paraproteinaemic neuropathy. Bailleres Clin Neurol 1994;3:129-147.
11. Latov N. Pathogenesis and therapy of neuropathies associated with monclonal gammopathies. Ann Neurol 1995;37(Suppl):S32-S42.
12. Ilyas AA, Chou DK, Jungalwala FB, Costello C, Quarles RH. Variability in the structural requirements for binding of human monoclonal anti-myelin-associated glycoprotein immunoglobulin M antibodies and HNK-1 to sphingoglycolipid antigens. J Neurochem 1990;55:594-601.
13. Kornberg A, Pestronk A. Chronic motor neuropathies: diagnosis, therapy and pathogenesis. Ann Neurol 1995;37(Suppl):S43-S50.
14. van der Mechè FVD, van Doorn PV. Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol 1995; 37(Suppl):S14-S31.
15. Quarles RH, Dalakas MC. Do anti-ganglioside antibodies cause human peripheral neuropathies? J Clin Invest 1996;97:1136-1137.
16. Latov N. Antibodies to glycoconjugates in neuropathy and motor neuron disease. Prog Brain Res 1994;101:295-303.
17. Ayadi H, Mihaesco E, Congy N, et al. H chain V region sequences of three human monoclonal IgM with anti-myelin-associated glycoprotein activity. J Immunol 1992;148:2812-2816.
18. Weng NP, Yu-Lee LY, Sanz I, Patten BM, Marcus DM. Structure and specificities of anti-ganglioside autoantibodies associated with motor neuropathies. J Immunol 1992;149:2518-2529.
19. Lee G, Ware RR, Latov N. Somatically mutated member of the human V lambda VIlI gene family encodes anti-myelin-associated glycoprotein (MAG) activity. J Neuroimmunol 1994;51:45-52.
20. Paterson G, Wilson G, Kennedy PG, Willison HJ. Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. J Immunol 1995;155:3049-3059.
21. Willison HJ, O'Hanlon GM, Paterson G, et al. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest 1996;97:1155-1164.
22. Jacobs B, Doorn Pv, Schmitz P, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome. Ann Neurol 1996;40:181-187.
23. Ho TW, Mishu B, Li CY, et al. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
24. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775.
25. Aspinall GO, McDonald AG, Pang H, Kurjanczyk LA, Penner JL. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barre syndrome. Biochemistry 1994;33:241-249.
26. Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791-793.
27. Salloway S, Mermel LA, Seamans M, et al. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect Immun 1996;64:2945-2949.
28. Latov N, Wirguin I, Suturkova-Milosevic L, Briani C. Mechanism of induction of anti-ganglioside antibodies in immune mediated neuropathy [abstract]. J Neurochem 1996;66:S97C.
29. Mendell JR, Sahenk Z, Whitaker JN, et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody. Ann Neurol 1985; 17:243-254.
30. Hammer JA, O'Shannessy DJ, De Leon M, et al. Immunoreactivity of PMP-22, P0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies. J Neurosci Res 1993;35:546-558.
31. Snipes GJ, Suter U, Shooter EM. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J Neurochem 1993;61:1961-1964.
32. Kohriyama T, Kusunoki S, Ariga T, et al. Subcellular localization of sulfated glucuronic acid-containing glycolipids reacting with anti-myelin-associated glycoprotein antibody. J Neurochem 1987; 48:1516-1522.
33. Kanda T, Yoshino H, Ariga T, Yamawaki M, Yu RK. Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. J Cell Biol 1994; 126:235-246.
34. Hays AP, Latov N, Takatsu M, Sherman WH. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 1987;37:242-256.
35. Willison HJ, Trapp BD, Bacher JD, et al. Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle Nerve 1988;11:1169-1176.
36. Kahn SN, Stanton NL, Sumner AJ, et al. Analysis of the feline immune response to human myelin-associated glycoprotein. J Neurol Sci 1989;89:141-148.
37. O'Shannessy DJ, Willison HJ, Inuzuka T, Dobersen MJ, Quarles RH. The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies. J Neuroimmunol 1985;9:255-268.
38. Yamawaki M, Vasquez A, Younes AB, et al. Sensitization of Lewis rats with sulfoglucuronyl paragloboside: electrophysiological and immunological studies of an animal model of peripheral neuropathy. J Neurosci Res 1996;44:58-65.
39. Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 1993;33:502-506.
40. Ogawa-Goto K, Ohta Y, Kubota K, et al. Glycosphingolipids of human peripheral nervous system myelins isolated from cauda equina. J Neurochem 1993;61:1398-1403.
41. Svennerholm L, Bostrom K, Fredman P, et al. Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta 1994;1214:115-123.
42. Corbo M, Quattrini A, Lugaresi A, et al. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol 1992;32:487-493.
43. Corbo M, Quattrini A, Latov N, Hays AP. Localization of GMl and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993;43:809-814.
44. Thomas FP, Adapon PH, Goldberg GP, Latov N, Hays AP. Localization of neural epitopes that bind to IgM monoclonal auto-antibodies (M-proteins) from two patients with motor neuron disease. J Neuroimmunol 1989;21:31-39.
45. Griffin JW, Li CY, Ho TW, et al. Guillain-Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-595.
46. Thomas FP, Trojaborg W, Nagy C, et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol (Berl) 1991; 82:378-383.
47. Santoro M, Uncini A, Corbo M, et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992;31:385-390.
48. Heiman-Patterson T, Krupa T, Thompson P, et al. Anti-GM1/ GD1b M-proteins damage human spinal cord neurons co-cultured with muscle. J Neurol Sci 1993;120:38-45.
49. Roberts M, Willison HJ, Vincent A, Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 1995;38:111-118.
50. Kusunoki S, Chiba A, Tai T, Kanazawa I. Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve 1993;16:752-756.
51. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller-Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
52. Ilyas AA, Quarles RH, Dalakas MC, Fishman PH, Brady RO. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann Neurol 1985;18:655-659.
53. Ohsawa T, Miyatake T, Yuki N. Anti-B-series ganglioside-recognizing autoantibodies in an acute sensory neuropathy patient cause cell death of rat dorsal root ganglion neurons. Neurosci Lett 1993;157:167-170.
54. Kusunoki S, Shimizu J, Chiba A, et al. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 1996;39:424-431.
55. Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barre syndrome and neurotransmitter release Lancet 1994;343:454-455.
56. Dyck PJ, Low PA, Windebank AJ, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991;325:1482-1486.
57. Dalakas M, Quarles R, Farrer R, et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy. Ann Neurol 1996;40:792-795.
58. Dalakas M. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: Present and future prospects. Ann Neurol 1995;37(Suppl 1):S2-S13.